7 industries with emerging wireless trends in 2014
Wireless devices are essential to most people's daily lives; mobiles, tablets, smart watches, Google Glass and other innovative tech is never more than an arm length away. In business, office accessories from printers to computer mice have gone wireless. Apps help us organize, prioritise, and sometimes even can turn off the lights at home from a remote location.
But how will this technology be applied this year - both in your personal and professional life? Several things influence where these trends will go: data analysis will determine the most efficient products and uses and businesses' adaptation of Bring Your Own Device (BYOD) policies will open the doors for a new wave of tech in the workplace
Below, Business Review Australia contributor Megan Iemma has outlined 7 industries that are trending towards wireless innovations.
More freighting companies and trucks will have trackable sensors embedded to analyse the speed, location and estimated time of arrival/departure of the vehicle. This will also help with deliveries, as goods will be able to be tracked with real time information and updates via an app by the consumer and/or business.
One of the emerging trends is remote automation of energy sources such as lighting and heating, which are controlled via a wireless device or sensors. This is leading to new markets/niches in manufacturing to provide this technology, such as the Belkin ‘WeMo’ which is being using for both business and home automation.
Emerging trends suggest there will be less office staff as cloud-based systems and wireless devices integrate more effectively. There is already software such as GeoOp with GPS tracking for service-based businesses such as tradies, removalists and anything that requires jobs to be dispatched. This software assists businesses to track employees and deploy jobs as they come in.
Data is becoming the key to retail success and customising an individual’s experiences, whether it is shopping for clothes or even groceries. Managing this data in a single format will make small business owners and companies much more efficient with productivity and help deliver better service and products to the customer.
Consumers are currently using their mobile devices primarily for comparison shopping. Other products will be able to detect mobile devices and then send ads as soon as you pass by the sensor.
In 2014, major hotels will integrate more technology by providing hotel rooms/suites with wireless devices that control everything from opening blinds to delivering high-speed video/audio through WiFi.
It is essential for business travellers to be able to access the latest technology (such as inbuilt Apple TVs) and be able to run meetings from the comfort of their room, rather than need to use a meeting room at the hotel. Again, data plays an important part in analysing these trends and helps build a customised experience for the consumer.
Food and Drink
More restaurants will use mobile devices for menu ordering which will improve efficiency and front of house procedures. Employees will use MPOS (Mobile Point of Sale) units to finalise an order and use for customer feedback. Data such as when customers are coming in, ordering patterns and what are the most popular items will help with inventory and stock control. Information will be also be sent to mobile devices for feedback on meals, upcoming specials and sign up for engaging with the brand.
Wireless devices are helping medical practitioners in medical clinics and hospitals where they can access patient’s records in real time such as Smart Ward developed by Australian Matt Darling. Trends are emerging where there are less products and better systems to help avoid error in both aged care and hospitals.
In 2014, there will be more of an explosion of wearable devices that are used in healthcare and this information will be fed back to pharmacies, health care companies which will develop further products/apps to enhance the consumer experience.
Advanced Wearable technology other than smart watches will not only impact on how data is used, it will also improve the interaction between health-care practitioners. This will assist the monitoring of patients daily habits to enable more precise management of both medication and health conditions.
Ultimately in 2014, businesses will need to follow and act on these trends that are emerging in their industry. As consumers now have more access to information they will be seeking businesses that provide better service via the latest technology. Decision makers will need to invest in technology and not become ‘digital ostriches,’ otherwise businesses will be overtaken by others who take the initiative.
Seo JungJin: Who is EY’s World Entrepreneur of 2021?
Seo JungJin, founder of biopharma firm Celltrion, which most recently developed an antibody treatment for COVID-19, has been named the EY World Entrepreneur of the Year 2021, becoming the first South Korean in the award’s 21-year history.
Regarded as one of the world’s most prestigious business awards program for entrepreneurs, the EY Entrepreneur of the Year celebrates visionary and innovative leaders from across 60 countries who are transforming the world and fostering growth.
JungJin, who is now honoroary chairman of Celltrion Group, was up against a worthy cast of entrepreneurial competitors, taking the crown from among 45 award winners across 38 countries and territories.
Speaking during the virtual event, JungJin described his own interpretation of entrepreneurship as something that brings together “a group of people toward a common vision, embracing challenges as opportunities and committing oneself to contribute to the greater good”.
Why was JungJin crowned King Entrepreneur?
A South Korean native and now 63 years of age, JungJin founded biopharmaceutical firm Celltrion in 2003. In the nearly two decades since its founding, Celltrion has lived up to its goal of advancing health and welfare for all by developing ground-breaking drugs to treat autoimmune disease, various forms of cancer and, most recently, COVID-19.
The company, which JungJin started with just US$45,000 and five of his colleagues, has since growth to more than 2,1000 employees with sales permits in more than 90 countries and revenues exceeding US$1.69bn.
According to the panel, JungJin’s story is a shining example of the power of an unstoppable entrepreneur to change the world with the pandel moved by both his incredible story and his purpose-driven leadership, innovative mindset and entrepreneurial spirit.
Described by the chair of the EY judging panel Rosaleen Blair as “representing everything an unstoppable should be” from taking on the world’s biggest health care challenges to consistently creating long-term value for his company, JungJin’s story is one of incredible tenacity and perseverance that the judging panel felt most represented the entrepreneurial spirit.
“He’s taken breathtaking risks, both personal and professional, to found Celltrion and grow it into one of the world’s leading biopharmaceutical companies,” says Stasia Mitchell, EY Global Entrepreneurship Leader. “His passion for creating affordable, life-saving health care and flair for tackling global problems has led to many treatments that have helped millions of people worldwide and was especially evident this past year through the creation of a COVID-19 antibody treatment.”
How did JungJin get there?
JungJin's entrepreneurial journey started at an early age when he worked as a taxi driver to get himself through Konkuk University in Seoul, South Korea. After studying industrial engineering, he rose through the ranks of Daewoo Motor Co. before losing his job amid the carmaker’s financial troubles following the 1997 Asian economic crisis.
Following this, JungJin started collaborating with colleagues to explore business opportunities in different industries, though none delivered lasting success. The turning point came after he attended a talk hosted by renowned scholars, which inspired him to focus on the biopharmaceutical sector.
And so he founded Celltrion with just US$45,000 of his savings. The launch of Remsima, credited with being the world's first antibody biosimilar, quickly moved Celltrion up the ranks of the country's fairly underdeveloped pharmaceutical sector. Celltrion followed this success with the launch of drugs for breast cancer and lymphoma that today are being used worldwide.
With ambitions to be the world’s first in different areas, Celltrion has pioneered numerous uncharted areas to great success over the past two decades, most recently responding to the global pandemic by successfully developing an antibody treatment for COVID-19 and working to ensure a timely supply of the safe and effective treatment.
“When I first started, my vision was to help patients gain access to safe, effective and affordable medicines and thereby enhance the quality of people’s lives,” explains JungJin. “The success of Celltrion has enabled me to expand on this while finding new ways to fuel my entrepreneurial drive.”